Table 1.
Clinical and laboratory characteristics before ablation
| All, N = 132 | CB, n = 60 | RF, n = 72 | P Valuea | |
|---|---|---|---|---|
| Mean age, y | 67 ± 10 | 67 ±12 | 66 ±9 | 0.652 |
| Male sex | 76 (57) | 36 (60) | 40 (55) | 0.610 |
| HTN | 101 (76) | 54 (77) | 47 (65) | 0.155 |
| DM | 27 (20) | 16 (26) | 11 (15) | 0.081 |
| Dyslipidemia | 35 (26) | 19 (31) | 16 (22) | 0.224 |
| Laboratory data | ||||
| FBG, mg/dL | 106 ±23 | 105 ±28 | 106 ±18 | 0.735 |
| eGFR, mL/min/1.73 m2 | 66.2 ±16.6 | 66.1 ±16.1 | 66.4 ±17.1 | 0.930 |
| BNP, pg/mL | 110.3 ±160.1 | 100.8 ±168.6 | 118.5 ±153.1 | 0.533 |
Abbreviations: BNP, brain natriuretic peptide; CB, cryoballoon; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; FBG, fasting blood glucose; HTN, hypertension; RF, radiofrequency; SD, standard deviation.
Data are expressed as n (%) or mean ±SD.
a
P values represent the comparison of data between the CB and RF groups.